• share
• favorite_border

Rutgers, The State University of New Jersey, has released its Rutgers Research and Innovation Annual Impact Report for Fiscal Year 2024.

• share
• favorite_border

A catalyst that converts waste CO₂ to chemical products. A monoclonal antibody that could revolutionize the detection of tuberculosis. Both innovations were developed at rutgers, The State University of New Jersey, and both have received 2024 Edison Patent Awards.

• share
• favorite_border

Base editing technology invented at Rutgers, The State University of New Jersey, and exclusively licensed to Revvity, Inc. subsidiary Horizon Discovery, has been sub-licensed to biopharmaceutical company AstraZeneca to support its creation of cell therapies for the treatment of cancer and immune-mediated diseases.

• share
• favorite_border

Rutgers is part of a new federally funded regional collaboration to drive economic and technological advancements in photonics, the National Science Foundation (NSF) announced. The consortium, which includes researchers from Rutgers-Newark and Rutgers-New Brunswick, awarded a development grant from the NSF’s Regional Innovation Economic Engine consortium, led by Princeton University and co-led by Rowan University, with partners throughout New Jersey and neighboring states Delaware, Pennsylvania and New York.

• share
• favorite_border

In an effort to expand and enhance New Jersey’s research and innovation ecosystem, Rutgers Office for Research’s Innovation Ventures will participate in a technology transfer partnership with the New Jersey Association of State Colleges and Universities (NJASCU).

• share
• favorite_border

Rutgers, The State University of New Jersey, has earned prestigious accreditation from the Association for the Accreditation of Human Research Protection Programs (AAHRPP) for the first time. Through this coveted certification, Rutgers Human Research Protection Program (HRPP) and Institutional Review Board (IRB) join the elite ranks of University Human Research Protection programs.

• share
• favorite_border

As the United States and the world continue to battle COVID-19 and other zoonotic diseases, a group of scientists and experts from New Jersey, Delaware, Pennsylvania, Maryland, West Virginia and Virginia will convene for a Regional One Health Consortium Conference at Rutgers University. Participants will consist of scientists who will share data and expertise on how to address a variety of topics and diseases affecting the health of humans, animals and the environment across the region, including ticks and tick-borne diseases, mosquitoes, rabies, and bird flu.

• share
• favorite_border

Rutgers researcher, Grace Brannigan, has co-authored a study published in The Proceedings of the National Academy of Sciences (PNAS) that centers around the connection between gene mutations in protein sequences and diseases.

• share
• favorite_border

A Rutgers researcher will use genomics, genetics, and cell biology to identify and understand the corals’ response to heat stress conditions and to pinpoint master regulatory genes involved in coral bleaching due to global warming and climate change. The researcher and his team will use a novel gene-editing tool as a resource to knock down some gene functions with the goal of boosting the corals’ abilities to survive.

• share
• favorite_border

The Research Collaboratory for Structural Bioinformatics Protein Data Bank (RCSB PDB), headquartered at the Rutgers Institute for Quantitative Biomedicine, announces the expansion of its data storage capacity through the Amazon Web Services (AWS) Open Data Sponsorship Program. The AWS program is providing the RCSB PDB with more than 100 terabytes of storage for no-cost delivery of Protein Data Bank information to millions of scientists, educators, and students around the world working in fundamental biology, biomedicine, bioenergy, and bioengineering/biotechnology.

• share
• favorite_border

A pair of Rutgers researchers are teaming up to combat climate change and worldwide hunger at the same time. Yong Mao, associate research professor and lead biologist in the Laboratory for Biomaterials Science at Rutgers School of Arts and Sciences, and Joseph Freeman, professor, director of the Musculoskeletal Regeneration Laboratory, and graduate program director of biomedical engineering in Rutgers School of Engineering, will collaborate with Atelier Meats, a biotechnology company, to develop and produce lab-grown, structured meats.

• share
• favorite_border

In a landmark genetic study of more than 121,000 people, an international consortium called SCHizophrenia Exome Meta-Analysis (SCHEMA), led by researchers at the Broad Institute of MIT and Harvard, has identified extremely rare protein-disrupting mutations in 10 genes that strongly increase an individual's risk of developing schizophrenia. The Genomic Psychiatry Cohort (GPC) study, based at Rutgers, The State University of New Jersey and led by Drs. Carlos and Michele Pato, is a major contributor to this study and the second, complementary study, led by researchers at Cardiff University on behalf of the Psychiatric Genomics Consortium (PGC).

• share
• favorite_border

A Rutgers researcher’s new formula with Investigational New Drug (IND) status has successfully alleviated a patient’s long-term severe gastrointestinal (GI) illness associated with post-acute COVID-19 syndrome, or long-haul COVID, in a recent study. The study’s results on the formula developed by Liping Zhao, Ph.D., are now published in an article titled “Nutritional Modulation of Gut Microbiota Alleviates Severe Gastrointestinal Symptoms in a Patient with Post-Acute COVID-19 Syndrome” in mBio, a peer-reviewed journal of the American Society for Microbiology.

• share
• favorite_border

The Center for Tobacco Studies at Rutgers, The State University of New Jersey received a $2.6 million grant from the National Cancer Institute (NCI) to evaluate cigarette relighting – the practice of smoking a cigarette, extinguishing it, and lighting it again to smoke – as well as its consequences on health and efforts to quit smoking.

• share
• favorite_border

A Rutgers professor’s novel research into targeting and silencing defective, disease-causing RNA molecules has led to the launch of Ceptur Therapeutics, a startup that has raised $75 million in Series A funding. The initial research that led to the creation of Ceptur was conducted by principal investigator Samuel I. Gunderson, PhD, associate professor of molecular biology and biochemistry at Rutgers-New Brunswick’s School of Arts and Sciences. Gunderson’s research focused on Ribonucleic acid (RNA), specifically how to manipulate and control RNA to understand its functions and treat different genetic diseases, such as certain blood cancers and neurological disorders.

• share
• favorite_border

Rutgers, The State University of New Jersey joins the ranks of 53 premier international institutions from 12 countries invited to participate in the Novartis Institutes for BioMedical Research (NIBR) Global Scholars Program (NGSP). The competitive program is designed to support innovative thinkers from select academic institutions in translating their breakthrough science into transformative medicine and/or clinical research to improve the lives of patients.

• share
• favorite_border

A novel medical device that works as an absorbable implant for meniscal reconstruction, invented by researchers at Rutgers, The State University of New Jersey, received the 2021 Thomas Edison Patent Award in the Biotechnology category. The tissue-engineered implant treats meniscal tears to lessen or even entirely rid the need for a total knee replacement surgery. The implant also recreates the anatomy and fiber geometry of the meniscus.

• share
• favorite_border

The wind energy industry could soon count on a much-needed precise analysis to achieve an optimal balance for wind farm productivity and profitability, thanks to a team of researchers working with digitization, predictive and prescriptive analytics to bring down its operational costs.

• share
• favorite_border

Asthma and allergies are chronic health conditions that continue to adversely impact the quality of life for many around the world. Thanks to exciting breakthroughs by Mark Siracusa, a researcher at Rutgers, The State University of New Jersey, there may be early signs of light at the end of the tunnel.

• share
• favorite_border

Advancing its mission and leadership role to improve climate risk management critical to societal well-being, Rutgers, The State University of New Jersey will lead a multi-university Megalopolitan Coastal Transformation Hub (MACH) made possible by a grant through the National Science Foundation’s Coastlines and People (CoPe) Program with expected total funding of $19.9+ million over the next five years.